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Human intestinal spirochetosis – a review
Intestinale Spirochätose des Menschen – ein Review
Abstract
Human intestinal spirochetosis (IS) is a condition defined histologically
by the presence of spirochetal microorganisms attached to the apical
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cell membrane of the colorectal epithelium. Intestinal spirochetes
comprise a heterogeneous group of bacteria. In humans, Brachyspira
aalborgi and Brachyspira pilosicoli predominate. Prevalence rates of 1 Institute of Environmental
Medicine, Luzerner IS are low where living standards are high, in contrast to poorly de-
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veloped areas where IS is common. Homosexuals and HIV-infected in-
dividualsareathighriskofbeingcolonized.Clinicalsignificanceinindi-
vidual cases has remained unclear up to now. A review of the literature
assumes that invasion of spirochetes beyond the surface epithelium
may be associated with gastrointestinal symptoms which respond to
antibiotic treatment (metronidazole), whereas individuals lacking this
feature may be mostly asymptomatic. Of unknown reason, homosexual
and HIV-positive men as well as children are more likely to be sympto-
maticirrespectiveofinvasion.Rarecasesofspirochetemiaandmultiple
organ failure have been reported in critically ill patients with IS.
Keywords: human intestinal spirochetosis, microscopic colitis,
commensals, intestinal bacterial invasion, HIV-infection, spirochetemia
Zusammenfassung
Die intestinale Spirochätose des Menschen (IS) wird histologisch defi-
niert als ein dichter Saum von Spirochäten, der an der apikalen Zell-
membran des interkryptalen Epithels des Dickdarms haftet. Die intes-
tinalen Spirochäten umfassen eine heterogene Gruppe von Bakterien.
Beim Menschen sind ganz überwiegend Brachispira aalborgi und Bra-
chispirapilosicolinachweisbar.DiePrävalenzderISistniedriginRegio-
nen hohen Lebens- und Hygienestandards im Gegensatz zu ärmeren
Regionen, wo die IS häufig auftritt. Homosexuelle und HIV-positive
MännerhabeneinerhöhtesBesiedelungsrisiko.DieklinischeBedeutung
der IS ist im Einzelfall bislang fraglich. Die Literaturübersicht lässt an-
nehmen, dass bei der Schleimhautinvasion der Spirochäten klinische
Symptome wahrscheinlich sind, die gut auf eine antibiotische Therapie
(Metronidazol) ansprechen, während Personen ohne diesen Befund
wohl meist symptomlos bleiben. Aus unbekannten Gründen leiden Ho-
mosexuelle, HIV-positive Personen wie auch Kinder eher an Beschwer-
den unabhängig von der Invasivität der Spirochäten. Spirochätämien
und multiples Organversagen sind bei einzelnen, meist schwerkranken
Patienten mit IS beschrieben worden.
Schlüsselwörter: humane intestinale Spirochätose, mikroskopische
Kolitis, Kommensale, intestinale bakterielle Invasion, HIV-Infektion,
Spirochätämie
Background
First recognized in humans by van Leeuvenhoek in his
owndiarrhealstoolinthe17
thcentury(namedasanimal-
cules), intestinal spirochetes in humans are still poorly
understoodintheirbiology,origin,andstateascommens-
als or pathogens in the human large intestine. Originally
foundasadiseaseofeconomicdevastationinveterinary
medicine(e.g.inswine),intestinalspirochetesinhumans
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[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12].
In 1967, Harland and Lee coined the term intestinal
spirochetosis (IS), recognizing the adherence of spiro-
chetes to colorectal epithelium in histology and electron
microscopy, the characteristic appearance that is still
considered pathognomonic for a possible capacity to
cause human disease [2] (Figure 1, Figure 2, Figure 3,
Figure4,Figure5).Despiteimprovementsinthedetection
and identification of IS, it is still unclear whether this
conditionrepresentsanactualdiseaseprocess,orrather,
the organisms represent interesting intestinal colonizers
in men that does exclusively manifest in the large bowel.
Figure 1: Exfoliative cytology of the rectal mucosa in human
spirochetosis with many spirochetes between rod-like
bacteriae. Warthin-Starry silver stain. x600.
Figure 2: Histology of human intestinal spirochetosis.
Hematoxylin-Eosin. x350.
Figure 3: Human intestinal spirochetosis in the vermiform
appendix. Warthin-Starry silver stain. x350.
Figure4:Immunohistochemicaldetectionofhumanintestinal
spirochetosis with signs of invasion. Strept-Avidin technique.
x680.
Figure 5: Human intestinal spirochetosis in transmission
electron microscopy. x3500.
Epidemiology
In the veterinary world, IS has been linked to diarrheal
illnessinswine,poultry,dogs,cats,opossum,non-human
primates,andguineapigs.Thediseasecausessignificant
economic losses when it affects large numbers of swine,
leading to “porridge-like diarrhea”, malnutrition, de-
creased food intake, and declining growth rates [3].
Human disease is less well understood, though the
presence of intestinal spirochetes in stool has been
documentedmicrobiologicallythroughoutAfrica,Australia,
India, Indonesia, and much of the Western world for
decades (review: [4]).
Theprevalencedatastronglydependonthematerialand
the detection methods used (direct histology or poly-
merase chain reaction (PCR) of fecal samples or of
colorectal biopsies). A large study in Chicago in the early
1900s revealed a 28% prevalence of intestinal spiro-
chetes in the stools of healthy persons [5]. Studies of
stools in West Africa found close to a 100% rate of spiro-
chetes [6]. Prevalence rates in soldiers of Western Com-
mandduringtheearly1900sreached3.3%intheirstools
for those with previous bouts of dysentery [7]. It is note-
worthythatthepresenceofspirochetesinthestoolmight
not be associated with IS and with clinical symptoms.
In more recent times, the prevalence of intestinal spiro-
chetes in stools appears to correspond with habitation
in a developing region. Prevalence rates of 32.6% are
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chaetes were only recovered from 8 of 695 (1.2%) fecal
samplesthatwereobtainedfromothermainlynon-Abori-
ginal children and adults in Western Australia or the
NorthernTerritoryofAustralia,eventhoughmostofthese
individuals were suffering from gastrointestinal disturb-
ances [8]. Villages in India have shown rates as high as
64.3%inotherwisehealthyindividuals[6].Astudylooking
at hospitalized and healthy persons in Oman found pre-
valenceratesof11.4and26.7%,respectively[9].Astudy
inBaliin2002examined992fecalsamplesfrompeople
living in rural, urban, and suburban areas. In contrast to
theruralpredominanceseeninearlierstudies,prevalence
inBalivariedfrom3.3to23.4%,withthehighestpercent-
ages in the suburban areas [10]. Other studies reported
rates from 1.1 to 5% in most developed countries [4],
[6], [13], [14].
The highest rates of colonization of stools with intestinal
spirochetes in developed countries are found in homo-
sexualmalesandinhumanimmunodeficiencyvirus(HIV)-
infected individuals. In the United States, homosexual
males have shown rates of colonization as high as 20.6
to 62.5% [4], [15], [16], [17], [18], [19]. The reason for
this increased colonization in homosexual men is specu-
lative at best but has caused proponents to ponder
whether IS is sexually transmitted [17], [18], [19]. For
those with IS and HIV, there appears to be no correlation
with degree of immunodeficiency and extent of disease
[19].
Colonization of the colonic mucosa with intestinal spiro-
chetes (IS) is not limited to the homosexual population
in developed countries, as cases in heterosexual adults
havebeenreportedintheU.S.,Japan[20],Australia[21],
Denmark,Sweden,Switzerland,Norway,England,France
[22], Italy, Spain and Brasil [23] (review: [4]). Particularly
in children, IS may be associated with severe clinical
symptoms [24], [25], [26], [27], [28]. Intestinal spiro-
chetes have been documented in second trimester
fetuses while infections by Treponema pallidum, Lyme
and relapsing fever Borrelia and Leptospira were ruled
out.Fetaltissuesshowedabrisklymphocytic-plasmacytic
response in the intestinal mucosa. In all instances the
placentahadchorioamnionitisandseverechronicvillitis.
The placental findings suggest an ascending transamni-
otic infection [29].
Microbiology
As the modern classification of bacteria came to rely on
morphologicdifferencesatthelevelofDNAandRNA,the
spirochetes were divided into three phylogenetic groups.
The family Spirochaetaceae includes Borrelia, Spiro-
chaeta, Spironema, and Treponema; Leptospiraceae
contains Leptonema and Leptospira; and the intestinal
spirochetes of Brachyspira (Serpulina) are in the Bra-
chyspiraceae family (Table 1) [30].
Traditionally, Brachyspira and Serpulina were referred to
as separate genera; however, a lack of significant phylo-
genetic differences has led to the unifying classification
underBrachyspira,withthetwogenusnamesconsidered
interchangeable [31].
The two members of the Brachyspiraceae family most
commonly associated with human IS are Brachyspira
aalborgi and Brachyspira pilosicoli. B. aalborgi was first
identifiedinthestoolofapatientfromAalborg,Denmark
in 1982 [32]. In the years that followed, subsequent
cases of IS were assumed to be caused by B. aalborgi on
the basis of similar histologic appearance. However,
studies published in 1994 and 1996 reexamined the
stools using multilocus enzyme electrophoresis and yiel-
ded a predominance of B. pilosicoli [33], [34]. Addition-
ally, a study by Trivett-Moore et al. [35], published in
1998, looked at rectal biopsy specimens in homosexual
menandfoundonlyB.pilosicoli.Followingthesestudies,
most subsequent cases of IS were attributed to B.
pilosicoli. More recently, PCR-based assays have been
used to identify these fastidious organisms (see below).
MembersofthefamilyBrachyspiraceaearemorphologic-
ally similar to other spirochetes. The characteristic of all
spirochetes, movement through fluid environments, is
performed by rotation of flagellae. A central cylinder en-
closed by a cytoplasmic membrane is the basic morpho-
logic structure. The periplasmic space contains the axial
fibrils, the number of which varies for individual species.
Characteristics of B. aalborgi are the length: 2–6 μm;
diameter:0.2μm;slender,taperedpoint(causativeagent
of diarrhea in humans) [11], [12], [36]. Characteristics
of the weakly beta hemolytic B. pilosicoli are length:
4–20 μm; diameter: 0.2–0.5 μm; slender, tapered point
(causative agent of diarrhea in humans, pigs, dogs,
poultry) [3].
Both B. aalborgi and B. pilosicoli are slowly growing fas-
tidiousanaerobes,withestimatedgrowthtimesof6days
for B. pilosicoli and up to 2 weeks for B. aalborgi [36],
[21], [31], [35]. B. aalborgi is difficult to grow on artificial
culturemedia.Thefirstreportedisolationoftheorganism
from human feces was on brain heart infusion agar with
10% bovine blood and spectinomycin plus polymyxin B.
Incubation in an anaerobic jar allowed growth of larger
colonies, and growth was slightly improved at 38.5°C
than at 37°C [37], [38].
A report on antimicrobial susceptibility testing of B.
pilosicoli was published in 2003 [39]. Antimicrobial sus-
ceptibility was determined using Clinical and Laboratory
Standards Institute (formerly National Committee for
ClinicalLaboratoryStandards,orNCCLS)breakpointsfor
anaerobes, with isolates determined to be susceptible to
ceftriaxone,chloramphenicol,meropenem,metronidazole,
andtetracycline.Anarbitrarybreakpointwasestablished
forciprofloxacin,yieldinga60%resistancerate.Aslightly
better response rate to moxifoxacin was exhibited.
Erythromycin was not active against B. pilosicoli, but ap-
proximately 30% of erythromycin-resistant isolates were
susceptible to clindamycin.
The physiology of ruminal and intestinal spirochetes has
been reviewed by Stanton in 1998 [40].
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Clinical presentation, diagnosis,
and treatment
In many cases, the histological findings of IS are simply
an incidental discovery during a screening colonoscopy.
Symptomatic IS is most commonly accompanied by
complaintsofchronic(watery)diarrheaandvagueabdom-
inal pain without other apparent cause [4].
Thoughmildtomoderatediseasesymptomspredominate,
diseaseseveritycanrangefromasymptomatictoinvasive
and rapidly fatal. Several cases of invasive disease have
been reported [16], [17], [18], [19], [20], [22], [23], [41],
[42], [43], [44], [45], [46], [47], [48], [49], [50], [51],
[52], [53], [54]. Infected children usually complain of
diarrhea and may also present with nausea, weight loss,
and failure to thrive [24], [25], [26], [27], [28].
Co-infection with other enteric pathogens, including En-
terobius vermicularis, Helicobacter pylori, Shigella flexn-
eri, and Neisseria gonorrhoeae, is common, making the
question of clinical significance of IS a difficult one to
answer [17], [27], [54].
The endoscopic appearance of the colon lends very little
to the diagnosis. A literature review by Alsaigh and Fogt
[51] examined the documented endoscopic appearance
of15biopsyspecimensthatwerehistologicallyconsistent
with IS. A “polypoid” appearance was noted in seven pa-
tients, an “erythematous” area was seen in one patient,
a “lesion” was documented in another patient; and nor-
mal-appearing mucosa was noted in six patients. Hence,
the endoscopic appearance seems to contribute estab-
lishing the diagnosis of IS. But probably the spirochetes
werefoundcoincidentallyinbiopsiestakenfrommucosal
areas with irregular appearance, while in most cases the
mucosa colonized with spirochetes does not reveal any
gross irregularities. Colonic involvement has been docu-
mented from the proximal to the distal colon, including
the rectum. Involvement of the vermiform appendix has
also been reported [36], [45], [55].
The diagnosis of IS is traditionally based on the histo-
logical appearance of a diffuse blue fringe (seen in hem-
atoxylin-eosin stain), which is approximately 3 to 6 μm
thick, along the border of the intercryptal epithelial layer.
This finding is referred to as the “false brush border” [2],
[4](Figure2).WhenISissuspectedonthebasisoffinding
a blue fringe, Warthin-Starry or Dieterle silver impregna-
tion stains can be used to highlight the spirochetes in
fixed tissue samples (Figure 3) [4], [36], [43], [44], [45],
[46], [47], [48], [49], [50], [51], [52]. Recently, an anti-
bodyagainstBorreliaburgdorferihasbeenappliedinthe
immunohistochemicaldetectionofIS[53](Figure4).This
is a great diagnostic advantage.
Onelectronmicroscopy,thespirochetesareseentodock
perpendicularly to the intestinal epithelium [2], [4], [43],
[44],[45],[46],[47],[48](Figure5).Evenwithsignificant
diarrhea, the organisms have been described for a long
timetobetypicallynon-invasivemainlyseendockingonto
the cell surface mostly without actually penetrating the
membrane [2], [3], [11], [12], [44], [45], [46]. This view
has been challenged for the first time in electron micro-
scopic studies; additionally, a particular intraepithelial
mast cell and IgE plasma cell reaction has been found
[47], [48]. The epithelium undergoes changes, such as
blunting and loss of the microvilli, defects of the glycoca-
lyx,andswellingofthemitochondria[11],[12],[47].Cell-
membrane destruction can occur with the spirochetes
found in the intercellular spaces, within the surface epi-
thelial cytoplasm as intact organisms, or in phagolyso-
somes of macrophages as morphological altered spiro-
chetes [47], [48]. The amount of cell destruction usually
parallels the degree of invasion microscopically and clin-
ically, with more diarrhea typically seen in those with a
greater degree of microvillus destruction and a heavier
burden of spirochete attachment [16]. The diarrhea is
hypothesizedtobearesultofdecreasedresorptiveareas
of the damaged brush border [46], [48].
Two reports that reviewed histological changes in symp-
tomatic HIV-infected patients with IS noted a higher de-
gree of epithelial invasion, as well as more pronounced
loss of microvilli, in this population compared with non-
HIV-infected patients [16], [44]. Because diarrhea is
common in the HIV-infected population, subtle histologic
changescanbeeasilyoverlooked,withdiarrheaattributed
to a cause other than IS. Diagnosis of IS in the HIV-infec-
ted population requires pathologists to have a high level
of expertise in evaluating biopsy material from HIV-infec-
ted individuals [41].
Although the diagnosis of IS is usually made from histo-
logical examination of colorectal biopsy material, newer
methods for identifying the etiologic organism are being
explored but are not yet available commercially. PCR has
become one of the more reliable methods, targeting the
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for B. pilosicoli, B. hyodysenteriae, and S. intermedia
[56], [57]. Novel techniques such as immunomagnetic
separationshowpromiseforthefuture[58].Additionally,
fluorescent in situ hybridization with oligonucleotide
probes targeting 16S or 23S rRNA of B. aalborgi and B.
pilosicoli has been reported to be applicable in formalin-
fixed, paraffin-embedded intestinal biopsy specimens
[59], [60].
Nevertheless, although molecular genetic techniques
separate the different spirochetal species specifically,
the diagnosis of IS has still to be ascertained
morphologically in the biopsy material.
Nine cases of bacteremia caused by B. pilosicoli, mostly
inimmunocompromisedorcriticallyillpatientshavebeen
reportedintheEnglishliterature[61],[62],andaspecific
antibodytoB.aalborgicouldbeobtainedfromtheserum
of a patient with IS [63].
Response to antibiotic therapy for IS has varied. While
some patients may have complete remission of diarrhea
and normalization of the colorectal mucosa, others con-
tinue to have diarrhea with or without persistence of the
“false brush border”. We suggest that the amount of in-
vasiveness could correlate to the clinical signs and
symptoms and that patients with invasion of spirochetes
beyond the surface epithelium may be more apt to re-
spond to antibiotic therapy [4]. Generally, a trial of antibi-
otic therapy is warranted, most commonly with met-
ronidazole. Eradication of symptoms has been reported
with metronidazole administered at 500 mg q.i.d. for 10
days [50]. However, there are relatively little data pub-
lishedonrecommendedtreatmentsotherthansuccessful
casereports[12],[16],[46],[47],[53],[54].Symptomatic
improvement with the use of other antibiotics, including
clindamycin and macrolides, has been reported as well
[27].
New perspectives
AsthegenomesequenceofthemajorswineBrachyspira
hyodysenteriaewasrecentlydeciphered[64]thegenome
sequences of other pathogenic and non-pathogenic Bra-
chyspira species are becoming available. This data will
facilitate to reveal how these species have evolved and
adapted to the varied lifestyles in the complex and
changing nutritional and polymicrobial environment of
large bowels of different species, and why some but not
others can induce colitis and diarrhea [65].
Also, it will be possible to know what survival advantages
are gained by Brachyspira species through lateral gene
transfer events that seemed to be a dominant evolution-
ary force in several pathogens [66]. Particularly detailed
functional genomic analysis of Brachyspira species may
revealtheassociationwithchemotaxis,motility,invasive-
ness,proteases,hemolysinsandotherpotentialvirulence
factors and allow a differentiation between pathogenic
and non-pathogenic strains.
Conclusions
As advances in techniques for the detection of intestinal
spirochetesemerge,expertscontinuetoargueaboutthe
significance of this condition. Although treatment with
effective antibiotic does lead to symptomatic remission
and histological clearance in some patients, it is still un-
certain whether it was the elimination of the spirochetes
that led to the symptomatic improvement. Yet, other pa-
tients have no symptomatic relief with treatment despite
clearance of spirochetes. Diagnosis of apparent IS made
on the basis of histologic examination of biopsy speci-
mens from asymptomatic patients add further to the
confusion. On the other hand, the reported cases of IS
with septicemia and dissemination provide some validity
to the possible consequences of the condition. As IS is
more consistently recognized with better identification
techniques, it is hoped that the clinical significance of
this condition, particularly that of different strains and
theirpotentialofinvasiveness,willsoonbecomeevident.
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